The FDA has granted a breakthrough device designation to the BiVACOR Total Artificial Heart. Made of titanium, the device uses a magnetically levitated rotor to pump blood in adult patients with ...

The U.S. FDA’s decision to grant breakthrough device designation for Bivacor Inc.’s titanium total artificial heart (TAH) ...

The New York Times reported last week that Dr. Robert K. Jarvik, who led the development of the first artificial heart, ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to BiVACOR’s titanium Total Artificial ...

The company has so far treated patients who were weeks or months away from a transplant, but the device is theoretically ...

BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.

The heart consists of 4 chambers--2 atria (upper chambers) and 2 ventricles (lower chambers). Blood passes through a valve as it leaves each chamber of the heart. The valves prevent the backward flow ...